Recruiting

Observational Study

Sponsor:

Mayo Clinic

Code:

NCT06117930

Conditions

Malignant Central Nervous System Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Non-Interventional Study

Study Details

Brief summary:

This study explores how microorganisms in the gut can affect the growth and progression of brain tumors.

Conditions

Malignant Central Nervous System Neoplasm

Study ID

NCT06117930

Start date

Feb 28, 2024

Status verified date

Feb, 2026

Completion date

Dec 13, 2029

Anticipated

Primary completion date

Dec 13, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • All patients undergoing resection for a tumor of the central nervous system and associated controls are eligible to participate in this study.

Exclusion Criteria:

  • Excluded samples will be from patients younger than 18 years old. There are no exclusions due to race/sex.

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational

Participants undergo blood, tissue, saliva, urine and stool sample collection and complete questionnaires on study.

Interventions

Non-Interventional Study

Non-interventional study

Primary outcome measure

  • Establish the Mayo Clinic Florida Tumor-Gut Axis Biorepository [ Time Frame: Approximately 1 year, or until samples have been collected based on scheduled treatment. ]

Central Contacts and Locations

Central contacts

Clinical Trials Referral Office

855-776-0015mayocliniccancerstudies@mayo.edu

Locations

Mayo Clinic in Florida

Recruiting

Jacksonville, Florida, United States, 32224-9980

Contacts

Clinical Trials Referral Office

855-776-0015mayocliniccancerstudies@mayo.edu

Principal Investigator:

Alfredo Quinones-Hinojosa, M.D.

More Information

Sponsor

Mayo Clinic

Last update posted

Feb 5, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-02-05.